For Clinicians and Researchers

This section is designed for mental health clinicians, physicians, pharmacists, researchers, and anyone approaching DID from a professional or academic framework. It collects the published research from this site, the clinical series on DID underdiagnosis, and resources for assessment and treatment.

About the Author

Scott Beach, RPh, LCDC-II

Registered Pharmacist and Licensed Chemical Dependency Counselor with a research focus on dissociative disorders and relational safety in trauma-affected relationships. His peer-reviewed work produced two papers: a validated psychometric instrument (BSHAS) and a theoretical framework for intra-alter substructure in DID.

Published Research

Quantitative Study — 2026

The Beach Safety Hierarchy Assessment Scale

Development, Factor Structure, and Preliminary Validation of a Five-Level Model of Nervous System Readiness in Trauma-Affected Intimate Relationships

The BSHAS is a 25-item self-report and partner-report instrument that operationalizes a five-level hierarchy of nervous system safety in intimate relationships where one partner carries a dissociative or trauma-related diagnosis. It was developed to address a gap in the clinical literature: no validated instrument existed to help partners of DID/PTSD/C-PTSD individuals assess moment-to-moment nervous system readiness and calibrate their relational interventions accordingly.

Psychometric Summary

320
Participants (160 matched couples)
73.8%
Variance accounted for (5-factor EFA)
.79–.91
Cronbach’s alpha across levels
.73–.85
Dyadic concordance (self vs. partner report)

Key Findings

The L3–L4 Gap

Among participants with relational safety online (Level 3 scores > 3.0), cognitive engagement (Level 4) averaged 1.31 points lower on a 5-point scale (p < .001). Relational calm does not equal cognitive readiness. The window during which a person appears present and connected but is not yet available for complex relational processing is real, measurable, and larger than clinical intuition typically assumes.

Directional Observer Bias

Partners systematically overestimate physiological activation (+0.45 at Level 1) and underestimate relational and cognitive availability (−0.26 at Level 3, −0.31 at Level 4). This bias is directional, not random, and carries a direct clinical implication: partners should default to assuming the lower level when uncertain.

L1–L2 Dissociation

Physiological safety (Level 1) and emotional safety (Level 2) are empirically distinct (r = .28). Forty-four percent of respondents showed scores that differed by more than one full point between these levels. The two states require different partner responses and should not be conflated in clinical formulation.

Clinical Correspondence

The five BSHAS levels map onto the ISSTD three-phase treatment model: Levels 1–3 correspond to Phase 1 stabilization work; Level 4 to the Phase 1–2 transition; Level 5 to Phase 3 integration. The instrument provides a continuous, dyadic assessment tool within each phase rather than a categorical phase assignment.

Access This Research

Full Paper → doi.org/10.5281/zenodo.19688087

Permanently archived at Zenodo (CERN open-access repository). Indexed in OpenAIRE.

Extended research overview on this site →

Plain-language guide to the BSHAS paper →

BSHAS self-assessment tool →

Theoretical Framework — 2026

Intra-Alter Substructure in Dissociative Identity Disorder

A Theoretical Framework for State-Dependent Sub-Presentations Within Named Identity States

This paper addresses a clinical phenotype that appears in the literature of close observers, case reports, and community documentation but has no name or theoretical apparatus in the peer-reviewed literature: a named alter presenting with the same identity markers (name, self-concept, relational role) yet lacking access to a bounded portion of that alter’s episodic history, with no behavioral signal distinguishing the presentation and no self-awareness of the discontinuity.

Core Claim

A named alter may function as a broad cognitive schema whose sub-presentations are state-dependent instantiations, each carrying a bounded episodic memory archive, selected by polyvagal safety appraisal below conscious awareness.

Framework Components

Three-Layer Architecture

Sub-presentations are classified by detectability: (1) co-conscious sub-presentations detectable by both partners; (2) observer-detectable sub-presentations visible to a trained clinician but outside the system’s awareness; (3) covert sub-presentations accessible only through systematic longitudinal observation or structured interview. Most clinically significant presentations occur at layers two and three.

Polyvagal Selection Mechanism

Which sub-presentation fronts is governed by neuroception — the nervous system’s continuous, unconscious appraisal of safety. The same named alter accesses different episodic archives and presents with different behavioral signatures depending on whether the current environment registers as safe, ambiguous, or threatening. Selection is below the threshold of intentional control.

Integration Reconsidered

The paper proposes that for many systems, integration is more precisely described as the progressive convergence of sub-presentations under sustained relational safety — not the forced merger of named alters, but the gradual narrowing of intra-alter variance as neuroception consistently registers safety. This reconceptualization has clinical implications for how integration goals are framed and paced.

Theoretical Synthesis

The framework draws on four established bodies of work: structural dissociation theory (van der Hart, Nijenhuis, Steele), Putnam’s discrete behavioral states model, schema mode theory as applied to DID (Huntjens, Rijkeboer, & Arntz, 2019), and Porges’ polyvagal theory. Kluft’s (1988) clinical observations of isomorphic MPD and epochal division serve as the primary empirical anchor from the pre-unification literature.

Evidence Base

Case vignettes from eight years of longitudinal naturalistic observation in an intimate partnership are presented as lived-experience corroboration. The paper is explicit that this constitutes Level IV evidence and identifies specific empirical directions for formal validation: structured interview protocol development, EEG/fMRI paradigm design using alter-specific stimuli with episodic specificity manipulation, and cross-observer reliability studies for the three-layer classification.

Access This Research

Full Paper → doi.org/10.5281/zenodo.20769123

Permanently archived at Zenodo. Version 2 reflects post-publication citation corrections.

Extended overview on this site →

Plain-language schema summary →

Clinical Series

The DID Underdiagnosis Series

A five-part series examining the gap between expected and actual DID prevalence, the clinical mechanisms behind misdiagnosis, and the assessment tools that close the diagnostic gap. Each article includes primary source citations from the peer-reviewed literature.

Part 1

The Math Nobody in Psychiatry Wants to Do

Statistical case for the underdiagnosis problem: expected vs. diagnosed DID prevalence in the United States.

Part 2

Why DID Is Missed Clinically

Structural, educational, and systemic factors. Includes the Foote et al. outpatient study: 6% had DID, 95% unrecognized.

Part 3

When DID Looks Like Something Else

BPD, schizophrenia-spectrum, and ADHD differential: overlapping features and distinguishing clinical criteria.

Part 4

Assessment Tools and Clinical Sequence

DES, SCID-D-R, DDIS, MID; the six questions that should be routine in any trauma-adjacent assessment.

Part 5

The Trauma Connection

ACE data, Vonderlin et al. meta-analysis (65 studies), WHO global prevalence, and the logical incompatibility of high trauma rates with DID rarity.

The Statistical Report

An independent analysis estimating expected DID prevalence in the United States using CDC ACE data, community prevalence studies, and published trauma-DID development rates. Conservative estimate: 430,000 to 1.6 million expected cases vs. likely fewer than 100,000 diagnosed. Diagnostic gap ratio: 9:1 to 80:1.

Browse all research articles →

Pharmacological Considerations in DID

There is no FDA-approved pharmacotherapy for DID. Medication management requires understanding state-dependent pharmacokinetics, the risk of prescribing for comorbidities that may be misdiagnosed primary presentations, and the particular vulnerabilities of dissociative patients to sedative and hypnotic agents. Articles on medication considerations are forthcoming.

Clinical Resources

ISSTD

International Society for the Study of Trauma and Dissociation

isst-d.org →

ISSTD Treatment Guidelines

Guidelines for Treating DID in Adults, Third Revision. J Trauma Dissociation, 2011.

SCID-D-R

Steinberg (1994). Gold-standard structured interview for dissociative disorders. Requires formal training.

DES

Bernstein & Putnam (1986). 28-item screening. Score >30 warrants structured follow-up assessment.

CTAD Clinic

Complex Trauma and Dissociation clinical resource

cheshirepsychology.com →

Part of the Red Door Directory Network

Scroll to Top